The coenzyme A (CoA) biosynthetic pathway is known. d-Pantothenic acid (d-PaA) is first phosphorylated by pantothenate kinase (EC 2.7.1.33). The formed 4′-phosphopantothenic acid is conjugated with cysteine by phosphopantothenoylcysteine synthetase (EC 6.3.2.5) and then converted to 4′-phosphopantetheine by phosphopantothenoylcysteine decarboxylase (EC 4.1.1.36; a flavin mononucleotide enzyme). The final two steps are adenylation by phosphopantetheine adenylyltransferase (EC 2.7.7.3) to form dephosphoCoA and phosphorylation by dephospho-CoA kinase (EC 2.7.1.24) to form CoA. In mammals, the limiting step is the reaction of d-PaA→4′-phosphopantothenic acid (1, 2). If a compound can be synthesized by not using the step d-PaA→4′-phosphopantothenic acid, that compound might be superior to d-PaA with regard to being a precursor of CoA. A report focusing on the comparative activities of d-pantethine and d-PaA for various microorganisms has been published (6): the comparative growth-promoting activities of d-PaA and d-pantethine were determined for yeasts and lactic acid bacteria. In that report (6), d-pantethine was not or was only slightly active for all yeasts and some lactic acid bacteria, but was much more active than d-PaA for some lactic acid bacteria. Balibar et al. (7) reported that d-pantethine rescued deficiencies in phosphopantothenoylcysteine synthetase and phosphopantothenoylcysteine decarboxylase in Escherichia coli but not in Pseudomonas aeruginosa. In samples of rat livers, d-pantethine was shown to be more efficient than d-PaA in inducing the synthesis of CoA, but d-pantethine failed to affect the mitochondrial CoA contents if added to isolated mitochondria (8). Rana et al. (9) reported that d-pantethine rescued pantothenate kinase-associated neurodegeneration in Drosophilia. These reports (6-9) suggest that the efficacy of d-pantethine as a CoA precursor is dependent upon the particular organism and imply that d-pantethine may be a precursor of CoA as well as d-PaA in mammals. The synthetic pathway could be: 
The coenzyme A (CoA) biosynthetic pathway is known. d-Pantothenic acid (d-PaA) is first phosphorylated by pantothenate kinase (EC 2.7.1.33). The formed 4′-phosphopantothenic acid is conjugated with cysteine by phosphopantothenoylcysteine synthetase (EC 6.3.2.5) and then converted to 4′-phosphopantetheine by phosphopantothenoylcysteine decarboxylase (EC 4.1.1.36; a flavin mononucleotide enzyme). The final two steps are adenylation by phosphopantetheine adenylyltransferase (EC 2.7.7.3) to form dephosphoCoA and phosphorylation by dephospho-CoA kinase (EC 2.7.1.24) to form CoA. In mammals, the limiting step is the reaction of d-PaA→4′-phosphopantothenic acid (1, 2) . If a compound can be synthesized by not using the step d-PaA→4′-phosphopantothenic acid, that compound might be superior to d-PaA with regard to being a precursor of CoA. d-Pantethine is the stable disulfate form of d-pantetheine (the metabolic substrate which constitutes the integral part of CoA molecules and acyl carrier proteins). The reactive component of CoA and acyl carrier proteins is not d-PaA but instead the sulf-hydryl group donated from cysteine. Therefore, d-pantethine is a more metabolically active form of the precursor of CoA than d-PaA is. Consequently, d-pantethine has been used in clinical applications: oral supplementation of d-pantethine results in a tendency toward normalization of lipid values (3); d-pantethine administration has been shown to favorably affect parameters associated with the composition of platelet lipids and the fluidity of cell membranes (4, 5) .
A report focusing on the comparative activities of d-pantethine and d-PaA for various microorganisms has been published (6) : the comparative growth-promoting activities of d-PaA and d-pantethine were determined for yeasts and lactic acid bacteria. In that report (6) , d-pantethine was not or was only slightly active for all yeasts and some lactic acid bacteria, but was much more active than d-PaA for some lactic acid bacteria. Balibar et al. (7) reported that d-pantethine rescued deficiencies in phosphopantothenoylcysteine synthetase and phosphopantothenoylcysteine decarboxylase in Escherichia coli but not in Pseudomonas aeruginosa. In samples of rat livers, d-pantethine was shown to be more efficient than d-PaA in inducing the synthesis of CoA, but d-pantethine failed to affect the mitochondrial CoA contents if added to isolated mitochondria (8). Rana et al. (9) reported that d-pantethine rescued pantothenate kinase-associated neurodegeneration in Drosophilia. These reports (6) (7) (8) (9) suggest that the efficacy of d-pantethine as a CoA precursor is dependent upon the particular organism and imply that d-pantethine may be a precursor of CoA as well as d-PaA in mammals. The synthetic pathway could be: d-pantethine→d-pantetheine→ 4′-phosphopantetheine→dephospho-CoA→CoA and/or d-pantethine→d-pantetheine→d-PaA→4′-phosphopantothenic acid→4′-phosphopantothenylcysteine→4′-phosphopantetheine→dephospho-CoA→CoA. The synthetic pathways might differ organ to organ. d-Pantethine is a compound in which two molecules of d-pantetheine bind through S-S linkages. d-Pantethine is available from commercial sources as well as d-pantothenic acid. We investigated if d-pantethine has equivalent vitamin activity to that of d-PaA by comparison of the recovery from d-PaA deficiency in rats.
MATERIALS AND METHODS
Chemicals. Vitamin-free milk casein, sucrose and l-methionine were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Corn oil was obtained from Ajinomoto (Tokyo, Japan). Gelatinized cornstarch, a mineral mixture (AIN-93G mineral mixture) (10) and a vitamin mixture (nicotinic acid-free AIN-93 vitamin mixture containing 25% choline bitartrate) (10) were obtained from Oriental Yeast Co., Ltd. (Tokyo, Japan).
Calcium d-pantothenate (C18H32N2O10-Ca5476.54) (Fig. 1) , dephospho-CoA, CoA trisodium salt, and acetylCoA were purchased from Wako Pure Chemical Industries. d-Pantethine (C22H42N4O8S25554.72) (Fig. 1 ) was a gift from Daiichi Fine Chemicals (Takaoka, Japan). All other chemicals used were of the highest purity available from commercial sources.
Animals and treatment. The care and treatment of the experimental animals conformed to the guidelines for the ethical treatment of laboratory animals set by the University of Shiga Prefecture (Shiga, Japan). The room was maintained at a temperature of ~22˚C and ~60% humidity. A 12-h light-dark cycle (06:00-18:00/18:00-06:00) was also maintained. Male 3-wk-old Wistar rats obtained from CLEA Japan, Inc. (Tokyo) were divided into two groups (d-PaA-deficient group n515; control group n55). Each rat was housed in a metabolism cage CT-10 (CLEA Japan). Rats in the control group had free access to a chemically defined diet (d-PaA-containing diet, Table 1 ) for 54 d (used as a positive control). The PaA-containing diet contained 16.0 mg of Ca-pantothenate/kg, which is equivalent to 67 mmol PaA/kg. Rats in the d-PaA-deficient group had free access to a d-PaA-free diet (Table 1) for 47 d and, at day 48, they were divided into three groups; group 1 was the d-PaA-free diet group (n55) (used as negative control); group 2 was the d-PaA-containing diet group (n55); and group 3 was the d-pantethine-containing diet group (n55). The d-pantethine-containing diet contained 18.2 mg of d-pantethine/kg, which is equivalent to 66 mmol of PaA/kg. Rats were kept for 7 d. Twentyfour-hour urine samples from 09:00 to 09:00 on the last day of the experiment (day 53 to day 54) were collected in amber bottles containing 1 mL of 1 mol/L HCl and stored at 225˚C until use. Rats were decapitated at around 09:00-10:00 am on day 55. Blood was collected and various tissues were removed. Plasma was obtained from the whole blood and preserved at 225˚C until needed. Tissues were stored at 280˚C to prevent breakdown of dephospho-CoA, CoA, and acetyl-CoA (11) . The free form of d-PaA in urine and plasma was measured. Levels of free d-PaA, dephospho-CoA, CoA and acetyl-CoA in tissues were measured.
Analyses. Dephospho-CoA, CoA, and acetyl-CoA: The concentrations of standard samples of dephospho-CoA, CoA, and acetyl-CoA were determined by using molar absorbancies of 13,300 at 259 nm, 16,000 at 260 nm, and 14,000 at 259 nm, respectively. These standard samples were dissolved in 50 mmol/L KH2PO4-K2HPO4 buffer (pH 7.0). Frozen tissues samples (280˚C; ca. 0.2 g) were added directly to 10-volumes of 5% 5-sulfosalicylic acid containing 50 mmol/L 1,4-dithiothreitol (DTT) and homogenized with a Teflon/glass homogenizer. Homogenates were centrifuged at 12,000 3g for 10 min at 4˚C. The supernatant was obtained and passed through a 0.45-mm filter (Millipore, Bedford, MA, USA) and the filtrate (20-50 mL) was injected directly into a high-performance liquid chromatography (HPLC) system. The contents of dephospho-CoA, CoA, and acetyl-CoA were measured as follows. The method employed a Tosoh TSK-GEL ODS-100V (250 mm34.6 mm I.D., particle size 5 mm) column eluted with 100 mmol/L NaH2PO4 and 75 mmol/L CH3COONa (pH was adjusted to 4.6 Frozen tissue samples (280˚C; ca. 0.2 g) were thawed, minced, and added to 10 volumes of 50 mmol/L KH2PO4-K2HPO4 buffer (pH 7.0). Suspensions were homogenized with a Teflon/glass homogenizer. Homogenates were incubated at 37˚C overnight to convert the free form of d-PaA from the bound type of pantothenate compounds such as pantetheines, CoA, dephospho-CoA, and acyl-CoA. The reaction was stopped by placement into a boiling water bath for 5 min. After cooling, the mixture was centrifuged at 10,000 3g for 10 min at 4˚C. The supernatant was retained and precipitated materials extracted with 2 mL of water and the supernatant retained. Both retained supernatants were combined, and the extract used for measuring d-PaA levels using Lactobacillus plantarum ATCC 8014 (12) .
The content of the free form of d-PaA was measured directly without incubating homogenates at 37˚C overnight using Lactobacillus plantarum ATCC 8014 (12) .
Statistical analyses. Each value is expressed as the mean6SE. Data were assessed using the KolmogorovSmirnov test to examine the distribution type; if data did not exhibit a normal distribution, they were logarithmically transformed prior to analyses. Statistical significance was determined by one-way ANOVA and was followed by Tukey's multiple-comparison test. p,0.05 was considered significant. All statistical analyses were undertaken using GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, USA).
RESULTS

Body weight and weights of various tissues
Feeding of the d-PaA-free diet reduced the food intake The extent of recovery was also investigated with respect to the levels of tissue weights ( Table 2) . Weights of the liver and spleen were lower in the negative control than in the positive control group. The changing from the d-PaA-free diet to the d-PaA-containing or d-pantethine-containing diets resulted in the recovery of the weights of the liver and spleen. The weights of the heart, kidneys, testes, and gastrocnemius muscle were lower in the negative control than in the positive control groups. The change from the d-PaA-free diet to the d-PaA-containing or d-pantethine-containing diet did not result in the complete recovery of the weights of those tissues. Values are nmol/g of tissue (except for urine and plasma) and means6SE for 5 rats. Statistical significance was determined by one-way ANOVA followed by Tukey's multiple-comparison test. Values with different superscript letters in a same row are significantly different at p,0.05. 1 Urine samples (from 09:00 at day 53 to 09:00 at day 54) were collected. 2 The content of free d-PaA in urine or the extract from each tissue was measured by a microbiological method. 3 The content of total d-PaA was measured by a microbiological method after the extract from each tissue had been treated by phosphatase and pantetheinase. 4 Could not be measured by the HPLC method (11). Conventional nutritional markers such as bodyweight gains (14) (15) (16) (17) and tissue weights (14) were compared between d-PaA and d-pantethine (Fig. 2 and Table 2 ). Differences in recoveries of body-weight gains and various tissue weights in d-PaA-deficient rats were not observed between the two groups fed d-PaA-and d-pantethine-containing diets. The weight of the testes decreased to 70% compared with the positive control group upon feeding the d-PaA-free diet ( Table 2 ). The weight of the testes was not rescued by feeding the diets containing d-PaA or d-pantethine for 7 d. d-PaA deficiency may be reflected most readily in the testes, and testicular tissue may show the slowest recovery from d-PaA deficiency (18) . A characteristic phenomenon was observed: body-weight gains (Fig. 2B) were higher in the groups of the "d-PaA-free diet for 47 d→d-PaAcontaining diet for 7 d" and the "d-PaA-free diet for 47 d→d-pantethine-containing diet for 7 d" than in the group of the "d-PaA-containing diet for 47 d→d-PaAcontaining diet for 7 d (positive control)" even though the food intakes for the two groups were identical. These findings could be because secretion of growth hormone in d-PaA-deficient rats was increased.
The physiological functions of d-PaA are focused on CoA and acetyl-CoA which is a key intermediate of energy production, certain types of metabolism (e.g., cholesterol) and the acetylation of some important proteins. Therefore, knowing the concentrations of CoA and acetyl-CoA in biological materials is very important from a nutritional viewpoint because low concentrations of these intermediates can cause metabolic disorders. The concentrations of CoA and acetyl-CoA were not as reduced by feeding the d-PaAfree diet compared with the values seen in rats fed the d-PaA-containing diet (though the values in the livers were exceptions) ( Table 3 ). The most striking finding was that the concentrations of the free form of d-PaA were much lower in the negative control group than in the positive control group. The decreased levels of the free form of d-PaA were recovered by feeding the diets containing d-PaA or d-pantethine for 7 d except for the amount of urinary excretion (Table 3) (19) . A greater amount of urinary excretion of d-PaA was lower in the negative control than in the positive control (Table 3) . Although the amounts were increased by feeding the diets containing d-PaA or d-pantethine, the amounts were lower compared with those seen in the positive control group. However, the amount of urinary excretion between the groups fed the d-PaA-and d-pantethinecontaining diets was not significantly different. These findings also suggest that almost all of d-pantethine is metabolized to CoA via d-PaA. Therefore, the pathway d-pantethine→d-pantetheine→4′-phosphopantetheine might not operate in rats.
In conclusion, the biological efficiency for recovery in d-PaA-deficient rats between d-PaA and d-pantethine was equivalent. d-pantethine was not superior to d-PaA for recovering the d-PaA-deficient state in rats.
